Keynotes
Keynote at Merck R&D Day, Darmstadt October 2024 - AI in pharma - between hope, hype and fear
Bioscience Keynotes: Future-Focused, Scientifically Grounded
I offer keynote packages in both English and German, combining deep scientific expertise with forward-looking insights into transformative trends such as Artificial Intelligence in Biotech, Longevity Science, Biotech Leadership, and many more.
My keynotes are ideal for a variety of formats—from major corporate conferences and innovation summits to online webinars and multi-day leadership retreats. Whether you're looking for a high-level biotech trends keynote or an in-depth session on a specific emerging technology, I deliver engaging, evidence-based presentations tailored to your audience.
“Louise captivated the audience from start to finish – talking about the future of artificial intelligence in drug development (!). Refreshingly nuanced take. We’d love to have her again. Highly recommended!”
”
CDL-Berlin Health talk: “New tech, new talent, new challenges – biotech leadership in the age of AI”, Berlin February 2025, Foto by Ana Torres
I cover a broad range of topics, including:
How AI is reshaping drug discovery and diagnostics
The future of biotechnology and life sciences
Leadership in the age of AI
The future of medicine
Longevity and the science of healthy aging
All keynotes can be customized to highlight the biotech innovations most relevant to your organization, industry, or strategic goals.
Learn more here Keynotes (zukunftsinstitut.de) or email louisevonstechow@gmail.com
“The keynote “Artificial Intelligence – Between Hope, Hype, and Fear” was excellent. Dr. Louise von Stechow effectively discussed how AI can improve drug development and diagnostics, but also addressing the industry’s challenges. I especially valued the examples that showcased both the potential and risks of AI in a broader context. Overall, it was an inspiring session that prompted us to think critically about AI’s application in our work. Thank you for this engaging presentation.
”
Keynote at Merck R&D Day, Darmstadt October 2024 - AI in pharma - between hope, hype and fear
KEYNOTE TOPICS
-
AI is everywhere—it brings hopes of accelerating industrial processes and making our lives easier and our work more efficient. It also brings fears of unexplainable black box calculations, of unintended consequences, and human job loss.
In the pharmaceutical industry, AI opens up the possibility of developing medications more quickly and tailoring them more precisely to the needs of individual patients.
But to truly revolutionize the multibillion-dollar process of drug development using AI, it requires the right strategies, technological foundations, and, above all, high-quality data.
In this keynote, I explore the potential of AI beyond the hype and draft scenarios of how AI-driven drug development could look like.
-
How will the medicine of the future look? Healthcare and medicine are on the verge of transformative change, driven by new technologies such as artificial intelligence, telemedicine, and wearable devices.
Alongside the technologization and virtualization of medicine, there is a shift from reactive "fix the broken" approaches to preventative strategies and from one-size-fits-all treatments to personalized medicine.In this future, human healthcare professionals and machines will work hand-in-hand to deliver the best possible care, with empowered patients acting as equal decision-makers who understand and access their own healthcare data. However, a darker scenario could see medicine becoming fully industrialized and dehumanized.
In this keynote, I outline the key trends shaping the future of medicine and discuss the opportunities and risks that accompany these developments.
-
What if aging wasn’t inevitable? In this thought-provoking keynote, I explore how cutting-edge biotechnology, genetic research, and AI are reshaping our understanding of aging—not as a natural decline, but as a process that can be slowed, altered, or even reversed.
From the work of pioneering companies like Altos Labs to the ethical and societal questions raised by radically extended lifespans, this keynote blends deep scientific insight with a broader cultural lens. It is designed to challenge assumptions, inspire new perspectives, and equip your audience with a clear understanding of where longevity science is headed—and what it means for us all.
By the end of the keynote, the audience won’t just be asking “Can we live longer?”—they’ll be asking “How will we live differently if we do?”
-
Artificial intelligence feels omnipresent—especially since large language models like ChatGPT have entered our personal devices and workflows. In healthcare, pharma, biotech, and MedTech, AI has sparked extraordinary hopes: faster drug discovery, smarter diagnostics, and more personalized medicine.
Yet ten years into the so-called AI revolution, with billions invested and over 100 AI-discovered molecules in clinical trials, the results remain mixed. Industry leaders face a challenging paradox: enormous potential on one hand, and persistent uncertainty on the other.
In this keynote, we take a grounded look at the true state of AI in biotech and pharma. We’ll unpack:
What’s working, what’s still aspirational
The technological, regulatory, and cultural frictions slowing adoption
Why strategic entry—even on a small scale—is essential to build internal AI literacy and resilience
By the end of the keynote, the audience will gain a clear-eyed perspective on how to cut through the hype and move toward thoughtful, strategic adoption—positioning AI not as a buzzword, but as a catalyst for real innovation.
“Louise was able to create a talk on a complex topic from scratch and adapt it to a diverse and expert audience. She communicated in a relaxed and open tone even in a challenging environment and “stadium-like” stage. Recommended!”
CDL-Berlin Health talk: “New tech, new talent, new challenges – biotech leadership in the age of AI”, Berlin February 2025, Foto by Ana Torres